These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 19731412)

  • 21. [Adjuvant therapy of breast cancer].
    Semiglazov VF; Abzumanov AS; Bozhok AA; Ivanov VG; Ivanova OA; Barash NIu; Topuzov EE; Seleznev IK; Migmanova NSh; Popova RT; Nurgaziev KSh
    Khirurgiia (Mosk); 2001; (5):52-60. PubMed ID: 11505673
    [No Abstract]   [Full Text] [Related]  

  • 22. [Palliative chemotherapy for metastatic breast cancer with capecitabine].
    Inaba T; Kashiwaba M; Takeda Y; Komatsu H; Tomisawa Y; Takiyama I; Wakabayashi G
    Gan To Kagaku Ryoho; 2009 May; 36(5):769-72. PubMed ID: 19461175
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A case of capecitabine-induced hyperpigmentation and radiation recall phenomenon.
    Ghosal N; Misra V
    Clin Oncol (R Coll Radiol); 2009 Oct; 21(8):632. PubMed ID: 19304468
    [No Abstract]   [Full Text] [Related]  

  • 24. Neoadjuvant treatment with trastuzumab in HER2-positive breast cancer: results from the GeparQuattro study.
    Untch M; Rezai M; Loibl S; Fasching PA; Huober J; Tesch H; Bauerfeind I; Hilfrich J; Eidtmann H; Gerber B; Hanusch C; Kühn T; du Bois A; Blohmer JU; Thomssen C; Dan Costa S; Jackisch C; Kaufmann M; Mehta K; von Minckwitz G
    J Clin Oncol; 2010 Apr; 28(12):2024-31. PubMed ID: 20308670
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacology and therapeutic efficacy of capecitabine: focus on breast and colorectal cancer.
    Aprile G; Mazzer M; Moroso S; Puglisi F
    Anticancer Drugs; 2009 Apr; 20(4):217-29. PubMed ID: 19247178
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Parotid gland metastasis of a breast cancer.
    Perez-Fidalgo JA; Chirivella I; Laforga J; Colio JM; Blanes MD; Baydal R; Roselló S; De-la-Morena E; Lluch A
    Clin Transl Oncol; 2007 Apr; 9(4):264-5. PubMed ID: 17462982
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improving adjuvant chemotherapy in breast cancer -- can we get more for less with TACT2?
    Johnson L; Cameron D; Barrett-Lee P; Canney P; Bliss JM
    Clin Oncol (R Coll Radiol); 2007 Oct; 19(8):593-5. PubMed ID: 17706405
    [No Abstract]   [Full Text] [Related]  

  • 28. Adjuvant therapy for breast cancer: we are solving the puzzle, but pieces are still missing.
    Pritchard KI
    J Natl Cancer Inst; 2007 Apr; 99(7):494-5. PubMed ID: 17405988
    [No Abstract]   [Full Text] [Related]  

  • 29. Granulomatous septal panniculitis associated with capecitabine (Xeloda).
    Dalmau J; Roé E; Puig L; Alomar A
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):121-2. PubMed ID: 18181993
    [No Abstract]   [Full Text] [Related]  

  • 30. [Prominent efficacy from capecitabine mono-therapy for a case with lymphangiosis carcinomatosa derived from recurrent breast cancer].
    Nozoe T; Mori E; Kono M; Iguchi T; Maeda T; Matsukuma A; Ezaki T
    Gan To Kagaku Ryoho; 2011 Mar; 38(3):427-9. PubMed ID: 21403447
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Capecitabine in breast cancer: current status.
    Smorenburg CH; Bontenbal M; Verweij J
    Clin Breast Cancer; 2001 Jan; 1(4):288-93; discussion 294. PubMed ID: 11899351
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adjuvant chemotherapy for lymph node-negative, estrogen receptor-negative breast cancer: a tale of three trials.
    Albain KS
    J Natl Cancer Inst; 2004 Dec; 96(24):1801-4. PubMed ID: 15601631
    [No Abstract]   [Full Text] [Related]  

  • 33. [Adjuvant therapy of colon cancer soon in tablet form].
    Krankenpfl J; 2005; 43(4-6):139. PubMed ID: 16171081
    [No Abstract]   [Full Text] [Related]  

  • 34. Could the hand-foot syndrome after capecitabine treatment be associated with better outcome in metastatic breast cancer patients?
    Kurt M; Aksoy S; Guler N
    Acta Oncol; 2006; 45(5):625-6. PubMed ID: 16864181
    [No Abstract]   [Full Text] [Related]  

  • 35. [Advances in research on capecitabine as adjuvant treatment for colon cancer after radical resection].
    Zhang SZ
    Zhonghua Zhong Liu Za Zhi; 2010 Nov; 32(11):801-3. PubMed ID: 21223682
    [No Abstract]   [Full Text] [Related]  

  • 36. [Oral fluoropyrimidines in the treatment of colorectal carcinoma].
    Porschen R
    Dtsch Med Wochenschr; 2003 Jun; 128 Suppl 2():S121-3. PubMed ID: 12817344
    [No Abstract]   [Full Text] [Related]  

  • 37. Impact of an all-oral capecitabine and vinorelbine combination regimen on functional status of elderly patients with advanced solid tumours: A multicentre pilot study of the French geriatric oncology group (GERICO).
    Rousseau F; Retornaz F; Joly F; Esterni B; Abadie-Lacourtoisie S; Fargeot P; Luporsi E; Servent V; Laguerre B; Brain E; Geneve J;
    Crit Rev Oncol Hematol; 2010 Oct; 76(1):71-8. PubMed ID: 20356760
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor topoisomerase II alpha status and response to anthracycline-based neoadjuvant chemotherapy in breast cancer.
    Nikolényi A; Sükösd F; Kaizer L; Csörgo E; Vörös A; Uhercsák G; Ormándi K; Lázár G; Thurzó L; Brodowicz T; Kahán Z
    Oncology; 2011; 80(3-4):269-77. PubMed ID: 21734419
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A case of metastatic breast cancer with bilateral hydronephrosis effectively treated with capecitabine].
    Yamauchi S; Nakagawa T; Kasahara M; Sugimoto H; Ishiba T; Tamura N; Nagahara M; Sato T; Sugihara K
    Gan To Kagaku Ryoho; 2012 Nov; 39(12):2077-9. PubMed ID: 23267982
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Capecitabine: the new generation of fluoropyrimidines in colorectal cancer.
    Iqbal S; Lenz HJ
    Expert Rev Anticancer Ther; 2004 Dec; 4(6):947-55. PubMed ID: 15606325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.